Filing Details

Accession Number:
0001209191-10-004523
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-22 12:00:00
Reporting Period:
2010-01-20
Filing Date:
2010-01-22
Accepted Time:
2010-01-22 17:50:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389072 Heartware International Inc. HTWR Surgical & Medical Instruments & Apparatus (3841) 980498958
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1404254 David Mcintyre C/O Heartware International, Inc.
205 Newbury Street, Suite 101
Framingham MA 01701
Cfo & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-20 491 $32.11 1,272 No 4 M Direct
Common Stock Disposition 2010-01-20 491 $38.11 781 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-01-20 491 $0.00 491 $32.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,393 2008-01-31 2010-01-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 800 Indirect See footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Restricted Stock Unit $0.00 2019-09-16 72,500 72,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-09-16 72,500 72,500 Direct
Footnotes
  1. The purchase price of US$32.11 has been converted from AU$35.00 at the spot rate on the date of the transaction.
  2. These shares were sold pursuant to a pre-arranged trading plan adopted by the reporting person on November 6, 2009 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  3. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $38.00 to $38.48. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  4. Shares held by Mr. McIntyre's spouse.
  5. The exercise price of US$32.11 has been converted from AU$35.00 at the spot rate on the date of the transaction.
  6. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  7. The restricted stock units become exercisable in three equal installments on September 16, 2010, September 16, 2011 and September 16, 2012, respectively.